Riffyn provides cloud software that structures scientific experimentation and delivers integrated process design and data analytics for life‑sciences R&D. Its platform automatically integrates heterogeneous experimental data in real time to feed machine‑learning and AI workflows using a patented scientific blueprints computer‑aided‑design approach. The technology enables continuous improvement of R&D processes, real‑time multi‑experiment data access, and global data integration for collaboration and machine learning. Riffyn reports customers include eight of the top 15 global biotechnology and pharmaceutical companies and cites a 30% reduction in effort to execute scientific workflows. The company also offers Riffyn Scientific Services for training, assay design, process improvement, and scientific data analysis consulting. Following a $15M Series B, Riffyn plans to expand global sales and scientific services and accelerate development of its process development and advanced data analytics capabilities. Riffyn develops a cloud-based computer-aided process design and data analytics platform for R&D organizations in the life science, chemical and food industries. Its software supports workflows from early-stage discovery through manufacturing development and pre-clinical trials. The company is led by founder and CEO Timothy Gardner. As of June 2016 the platform was in private beta and planned for commercial release in August 2016. Riffyn is based in Oakland, California. The company raised $4.6M in funding to accelerate the platform's launch.

Total raised

$20M

Funding rounds

2

Latest round

Series B

Latest activity

May 2019